Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: Studies in vivo and with cardiac myocytes

Hormone and Metabolic Research

Volumn 31, Issue 5, 1999, Pages 300-306

  Sugden, M C ^a,b   Priestman, D A ^a   Orfali, K A ^a   Holness, M J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiac Myocytes; Carnitine Palmitoyltransferase; Cyclic AMP; Fatty Acid Oxidation; Fatty Acids; Insulin; Rats; Tri iodothyronine

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; HEART; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HYPERTHYROIDISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033037589     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978741     Document Type: Article

References (32)

1. 1. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32: 217-38
2. 2. Sugden MC, Liu YL, Holness MJ. Glucose utilization and disposal in cardiothoracic and skeletal muscles during the starved-to-fed transition in the rat. Biochem J 1990; 272: 133-7
3. 3. Sugden MC, Holness MJ, Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J 1994; 8: 54-61
4. 4. McGarry JD. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biohem Soc Trans 1995; 23; 481-5
5. 5. McGarry JD. The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homeostasis and new insights into its molecular features. Biohem Soc Trans 1995; 23: 321-4
6. 6. Awan MM, Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 1993; 295: 61-6
7. 7. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-76
8. 8. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol 1994; 19: 59-113
9. 9. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischaemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995; 270: 17513-20
10. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986; 74: 81-8
11. 11. Garber DW, Everett AW, Neely JR. Cardiac function and myosin ATPase in diabetic rats treated with insulin and T4. Am J Physiol 1983; 244: H592-H598
12. 12. Gustafson TA, Markham BE, Morkin E. Effect of thyroid hormone on alpha-actin and myosin heavy chain gene expression in cardiac and skeletal muscles of the rat: measurement of mRNA content using synthetic oligonucleotide probes. Circ Res 1986; 59: 194-201
13. 2+-activated myosin ATPase activity and changes in myosin isoenzyme distribution in the diabetic rat heart. Endocrinology 1984; 114: 1678-85
14. +-dependent phosphatase in rat heart. Am J Physiol 1977; 232: C196-C201
15. 15. Kim D, Smith TW. Effect of thyroid hormone on sodium pump sites, sodium content, and contractile responses to cardiac glycosides in cultured chick ventricular cells. J Clin Invest 1984; 74: 1481-8
16. 16. Buccino RA, Spann JFJ, Pool PE, Sonnenblick EH, Braunwald E. Influence of thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest 1967; 46: 1669-82
17. 17. Seymour AML, Eldar H, Radda GK. Hyperthyroidism results in increased glycolytic capacity in rat heart. 31P-NMR study. Biochim Biophys Acta 1990; 1055: 107-16
18. 18. Sugden MC, Holness MJ, Liu YL, Smith DM, Fryer LG, Kruszynska YT. Mechanisms regulating cardiac fuel selection in hyperthyroidisrn. Biochem J 1992; 286: 513-7
19. 19. Fryer LGD, Holness MJ, Sugden MC. Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol 1997; 154: 513-22
20. 20. Nicholl TA, Lopaschuk GD, McNeil JH. The effects of free fatty acids and dichloroacetate on the isolated working diabetic rat heart. Am J Physiol 1987; 261: H1053-H1059
21. 21. Lopaschuk GD, Spafford M. Response of isolated working hearts from acutely and chronically diabetic rats to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow. Circ Res 1989; 65: 378-87
22. 22. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 1993; 264: 135-44
23. 23. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coronary Artery Disease 1996; 7L: 116-23
24. 24. Sugden MC, Liu YL, Holness MJ. Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat. Biochem J 1990; 271: 421-5
25. 25. Orfali KA, Fryer LG, Holness MJ, Sugden MC. Long-term regulation of pyruvate dehydrogenase kinase by high-fat feeding. Experiments in vivo and in cultured cardiomyocytes. FEBS Lett 1993; 336: 501-5
26. 26. Sugden MC, Orfali KA, Fryer LGD, Holness MJ, Priestman DA. Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase. Regulation by insulin, cyclic AMP and pyruvate. J Mol Cell Cardiol 1997; 29: 1867-75
27. 27. Drynan L, Quant PA, Zammit VA. The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat. Biochem J 1996; 318: 767-70
28. 28. Weis BC, Esser V, Foster DW, McGarry JD. Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. The minor component is identical to the liver enzyme. J Biol Chem 1994; 269: 18712-5
29. 29. Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 1994; 269: 26443-8
30. 30. Brown NF, Weis BC, Husti JE, Foster DW, McGarry JD. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 1995; 270: 8952-7
31. 31. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 1983; 214: 21-8
32. 32. Orfali KA, Fryer LGD, Holness MJ, Sugden MC. Interactive effects of insulin and triiodothyronine on pyruvate dehydrogenase kinase activity in cardiac myocytes. J Mol Cell Cardiol 1995; 27: 901-8